SCHEMBL21417015

SCHEMBL21417015

N#Cc1ccc2cc(C(=O)NC(C3CCCC3)C3(N)CC3)sc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 10/20 0.52
▸ DHPS P49366 1/20 0.43
▸ TACR2 P21452 1/20 0.40
▸ UTS2R Q9UKP6 1/20 0.40
▸ HTR3A P46098 3/20 0.40
▸ OPRM1 P35372 1/20 0.38
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ HDAC9 Q9UKV0 1/20 0.37
▸ HDAC5 Q9UQL6 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21417038 0.84 CHRNA7 (0.50) CHRNA7TACR2HTR3AOPRM1HDAC1
SCHEMBL21417016 0.79 CHRNA7 (0.54) CHRNA7OPRM1HDAC1HDAC3HDAC4
SCHEMBL21417050 0.79 CHRNA7 (0.54) CHRNA7HTR3AOPRM1HDAC1HDAC3
SCHEMBL20661376 0.78 CHRNA7 (0.50) CHRNA7UTS2RHTR3AOPRM1NPC1
SCHEMBL20618266 0.78 CHRNA7 (0.54) CHRNA7DHPSUTS2RHTR3AHDAC1
SCHEMBL21417023 0.73 CHRNA7 (0.53) CHRNA7HTR3AHDAC1HDAC3HDAC4
SCHEMBL21417331 0.73 CHRNA7 (0.52) CHRNA7HTR3AOPRM1HDAC1HDAC3
SCHEMBL18264115 0.72 CHRNA1 (0.57) CHRNA7DHPSUTS2RHTR3ANPC1
SCHEMBL18264114 0.72 CHRNA1 (0.57) CHRNA7DHPSUTS2RHTR3ANPC1
SCHEMBL21417305 0.71 HDAC3 (0.59) CHRNA7HTR3AHDAC1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233087-B1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS AXOVANT SCIENCES GMBH (DE) 2019-10-02 — — EP disclosed
Send feedback